Literature DB >> 11816444

Ex-vivo short-term culture and developmental assessment of Plasmodium vivax.

K Chotivanich1, K Silamut, R Udomsangpetch, K A Stepniewska, S Pukrittayakamee, S Looareesuwan, N J White.   

Abstract

A simple reproducible method for short-term ex-vivo Plasmodium vivax culture is presented in which glucose, ascorbic acid, thiamine, hypoxanthine, and 50% human AB+ serum are added to the standard P. falciparum in-vitro culture medium. Culture of freshly obtained blood samples from patients with acute vivax malaria with > 0.5% parasitaemia resulted in > 95% complete schizogony. Culture could be continued for 5-6 cycles without the addition of red cells. Criteria for staging the erythrocytic development of P. vivax in the first schizogonic cycle based on synchronous ex-vivo culture are presented. The asexual cycle was divided into 7 morphological stages: tiny ring (0-6 h), small ring (6-12 h), large ring (12-18 h), early trophozoite (18-28 h), late trophozoite (28-36 h), early schizont (36-42 h) and mature schizont (42-48 h). This simple method of culturing P. vivax ex vivo is suitable for antimalarial susceptibility and immunoparasitology studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11816444     DOI: 10.1016/s0035-9203(01)90113-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  27 in total

1.  In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Authors:  Feng Lu; Qi Gao; Kesinee Chotivanich; Hui Xia; Jun Cao; Rachanee Udomsangpetch; Liwang Cui; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

2.  Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.

Authors:  Bruce M Russell; Rachanee Udomsangpetch; Karl H Rieckmann; Barbara M Kotecka; Russell E Coleman; Jetsumon Sattabongkot
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 3.  Malaria diagnosis: a brief review.

Authors:  Noppadon Tangpukdee; Chatnapa Duangdee; Polrat Wilairatana; Srivicha Krudsood
Journal:  Korean J Parasitol       Date:  2009-05-26       Impact factor: 1.341

4.  Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.

Authors:  Kesinee Chotivanich; Jetsumon Sattabongkot; Yien Kyong Choi; Jae Sun Park; Juntima Sritabal; Chae Seung Lim; Rachanee Udomsangpetch; Nicholas J White; Won Ja Lee
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

Review 5.  Malaria in India: The Need for New Targets for Diagnosis and Detection of Plasmodium vivax.

Authors:  Swati Patankar; Shobhona Sharma; Pradipsinh K Rathod; Manoj T Duraisingh
Journal:  Proteomics Clin Appl       Date:  2018-01-11       Impact factor: 3.494

Review 6.  Primaquine treatment and relapse in Plasmodium vivax malaria.

Authors:  Kumar Rishikesh; Kavitha Saravu
Journal:  Pathog Glob Health       Date:  2016-02-18       Impact factor: 2.894

7.  Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.

Authors:  Voravuth Somsak; Chairat Uthaipibull; Parichat Prommana; Somdet Srichairatanakool; Yongyuth Yuthavong; Sumalee Kamchonwongpaisan
Journal:  Malar J       Date:  2011-10-07       Impact factor: 2.979

Review 8.  Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination.

Authors:  Alicia Arnott; Alyssa E Barry; John C Reeder
Journal:  Malar J       Date:  2012-01-10       Impact factor: 2.979

9.  Plasmodium vivax adherence to placental glycosaminoglycans.

Authors:  Kesinee Chotivanich; Rachanee Udomsangpetch; Rossarin Suwanarusk; Sasithon Pukrittayakamee; Polrat Wilairatana; James G Beeson; Nicholas P J Day; Nicholas J White
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

10.  Insights into the invasion biology of Plasmodium vivax.

Authors:  Surendra K Prajapati; Om P Singh
Journal:  Front Cell Infect Microbiol       Date:  2013-03-05       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.